Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis
04 Aug 2026 | 02:22 am |
Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.
The financing will support the advancement of Xeltis' aXess vascular access conduit toward US Food and Drug Administration (FDA) approval and commercial launch in the United States, while also supporting the continued development of the company's restorative cardiovascular technologies.
Horizon 3 led the round alongside a syndicate of existing and new investors, further strengthening Xeltis' position as it progresses the commercialisation of its pioneering endogenous tissue restoration platform.
The Pinsent Masons team was led by Melbourne-based corporate partner Andrew Fisken, with support from lawyers across APAC and Europe.
Commenting on the transaction, Andrew said: 'We are delighted to have advised our longstanding client Horizon 3 Healthcare on this strategic investment in Xeltis. The transaction highlights the continued investor confidence in innovative healthcare and medical technology businesses that have the potential to deliver meaningful clinical outcomes for patients globally. We look forward to seeing Xeltis continue to advance its groundbreaking technology towards regulatory approval and commercialisation in the United States and Europe.'
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons appoints Sarah Derbyshire as General Counsel
Multinational law firm Pinsent Masons has appointed Sarah Derbyshire as General Counsel.
Orbital launches Scots Law workflows for Commercial Real Estate following pilot with Pinsent Masons
Orbital has built specific workflows for Scottish commercial real estate work, built around Scots Law and Scottish real estate practice
Pinsent Masons advises on £230m plus Penta Real Estate and Staycity Group London aparthotel joint venture
Multinational law firm Pinsent Masons has advised Penta Real Estate on its investment into a landmark £230 million-plus joint venture with Staycity Group and advised the joint venture on the financing arrangements for the development, which will deliver a 350-room Wilde aparthotel in the heart of London's Farringdon district.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises SERT on transformational internalisation
Multinational law firm Pinsent Masons has advised Stoneweg Europe Stapled Trust (SERT) on its proposed aggregate c.€122 million acquisition of Stoneweg's pan-European investment management platform, a transformational transaction that will establish SERT as a fully integrated real estate owner, operator and investment manager with approximately €3.2 billion of assets under management.
Pinsent Masons strengthens IP offering with new patent attorney partner Fred Nicolle in London
Multinational law firm Pinsent Masons has appointed Fred Nicolle as a partner in its Intellectual Property (IP) team in London, strengthening the firm's European patents and life sciences offering.
Pinsent Masons advises FTI Consulting on sale of CX Lavender key client business to Omnicom Oceania
Multinational law firm Pinsent Masons has advised FTI Consulting, in its capacity as administrators of the CX Lavender group, on the sale of the company's key client-related business and associated workforce to Omnicom Oceania via its subsidiary, Clemenger BBDO Pty Ltd. The transaction completed in Q2 2026.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]